1. Goldstein, F. W. & Garau, J. (1997). 30 years of penicillin-resistant S. pneumoniae: myth or reality? Lancet350, 233–4.
2. Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroëdan, F. et al. (1998). Low dosage and long treatment duration of β-lactam:risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.Journal of the American Medical Association279, 365–70.
3. Nava, J. M., Bella, F., Garau, J., Lite, J.,Morera, M.-A., Martí, C. et al. (1994). Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clinical Infectious Diseases19, 884–90.
4. Pradier, C., Dunais, B., Carsenti-Etesse, H. & Dellamonica, P. (1997). Pneumococcal resistance patterns in Europe. European Journal of Clinical Microbiology and Infectious Diseases16, 644–7.
5. Dabernat, H., Geslin, P., Mégraud, F., Begue, P., Boulesteix, J., Dubreuil, C. et al. (1995). Study of nasopharyngeal (NP) carriage and effects of two antibiotics on potential pathogens in children with acute otitis media (AOM). In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract C-5, p. 40. American Society for Microbiology, Washington, DC.